Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Johnson & Johnson's Key Drugs Outperforming

Barron's - 6 Jul 2015 11:56
Johnson & Johnson's Key Drugs Outperforming Invokana/Invokamet, Xarelto, Invega Sustenna, Remicade could show second-quarter upside but Olysio may offset.
Full Article at Barron's

More Business News
3
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard